The mean intima media thickness (IMT) and plaque score from carotid ultrasonography are both widely used to evaluate macrovascular atherosclerotic change. The present study sought to examine which parameter more effectively predicts patient prognosis. This hospital-based cohort study included 356 patients with essential hypertension (mean age: 62.4±0.6). We investigated how the mean IMT and plaque score correlated with various parameters, including pulse wave velocity (PWV), and we assessed the ability of the mean IMT and plaque score to predict cardiovascular events and total mortality. The mean IMT and plaque score significantly correlated with systemic atherosclerotic change, target organ damage, age and PWV. Subjects with a higher mean IMT and subjects with higher plaque scores showed higher frequencies of stroke and total mortality. In addition, subjects with marginal thickening of the intima media (meanX0.7) showed a significantly higher frequency of stroke than subjects with a mean IMT of o0.7. After adjustment for traditional risk factors, plaque score was significantly and independently predictive of stroke, and the predictive ability of the plaque score for the onset of stroke was equivalent to that of PWV. The mean IMT and plaque score showed a nonsignificant trend of higher risk of mortality after adjustment for traditional risk factors. The mean IMT and plaque score were significantly correlated with systemic atherosclerotic change. We revealed that plaque score predicted the onset of stroke more accurately than the mean IMT, and the accuracy of this prediction was equivalent to that from PWV in hypertensive patients. We also showed that marginal thickening of the intima media (as measured by mean IMT) may be a predictor of stroke.
INTRODUCTION
Hypertension is one of the strongest and most prevalent risk factors for cardiovascular diseases (CVDs), 1,2 including stroke 3 and ischemic heart disease. 4 To prevent these conditions, we must assess systemic atherosclerotic change during hypertension management. Many methods have been reported to be useful for assessing arterial functions. For example, the presence of proteinuria or fundic sclerotic change have been reported to reflect microvascular atherosclerosis. Similarly, the resistive index has been reported to reflect vascular resistance; 5 reactive hyperemia has been reported to reflect endothelial function; 6 and pulse wave velocity (PWV) has been reported to reflect arterial stiffness. 7 Carotid ultrasonography is a simple and noninvasive method that is extensively used for evaluating atherosclerotic change 8 and is a well-studied method for detecting macrovascular atherosclerosis. 9 Mean intima media thickness (IMT) has been shown to be strongly associated with CVD and has become the most common marker evaluated by carotid ultrasonography. 10, 11 However, several investigators have suggested that IMT cannot qualitatively evaluate atherosclerotic changes, for example, lesions with a necrotic core, and that other parameters should be used to more precisely estimate the atherosclerotic state. 12 Studies have also indicated that plaque score is correlated with CVD. 13, 14 A review suggested that plaque score could predict coronary heart disease and might be more representative of atherosclerosis than mean IMT. 15 Furthermore, Ershova et al. 16 reported that plaque number, plaque score and markers of percent area of stenosis were more sensitive than mean IMT for cardiovascular risk estimation in patients with familial hypercholesterolemia.
However, it has not been clearly demonstrated which parameter in carotid ultrasonography can best predict patient prognosis in relation to stroke, coronary heart disease and mortality among hypertensive patients. Previously, we reported that increased aortic stiffness evaluated by carotid-femoral PWV (cfPWV) is more prognostic of cardiovascular events among hypertensive patients than several noninvasive atherosclerotic evaluations in a hospital-based cohort study. 17 In the current study, we conducted sub-analyses of the same cohort as studied in our previous study 17 and investigated whether mean IMT and plaque score correlated differently with various parameters, including PWV. We also assessed the hypothesis that plaque score was the more sensitive surrogate marker for systemic atherosclerotic change and could more accurately predict cardiovascular events among hypertensive patients. Furthermore, we assessed the correlation between marginal thickening of the intima media (as determined by mean IMT) and the onset of cardiovascular events.
METHODS

Study subjects and study design
This hospital-based cohort study was part of the Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) study, 17 in which a total of 813 serial outpatients who had been diagnosed with essential hypertension were sequentially recruited between January 1998 and June 2004 at Osaka University Medical Hospital. A total of 356 serial outpatients who had been diagnosed with essential hypertension and had undergone carotid Doppler ultrasonography were sequentially recruited in this study. Patients showing arterial fibrillation or having malignant diseases were excluded. The study protocol was approved by the hospital ethics committee, and written informed consent was obtained from all participants.
Follow-up evaluation
Clinical follow-up was conducted by clinical visits, mailed questionnaires and telephone contact every September starting in 2003. As we could not contact several subjects or their relatives, the follow-up rate of the NOAH study cohort was 94.3%.
The questionnaire included events related to hypertensive complications and cause of death. Patient responses were confirmed by checking the responses against patient medical sheets. The primary end points were the following: new onset of stroke (paralysis and diagnosis with CT and/or MRI); new onset of CVD, including angina pectoris (typical chest pain with ST segment changes on electrocardiograms); myocardial infarction (ST segmental elevation and 42-fold creatinine kinase elevation); heart failure (diagnosed using American Heart Association criteria); or rupture of an aortic aneurysm (diagnosed by ultrasound echography or CT). The average follow-up duration was 6.4 ± 0.2 years, which was measured as the interval from the initial evaluation to event onset or September 2010.
Blood pressure Measurements
Conventional blood pressure measurements were made by trained observers with an electronic sphygmomanometer (HEM-705IT or HEM-711, OMRON). Following the guidelines for hypertension management, clinic blood pressure was measured at least twice in the sitting position after a 5-min rest. If the difference between the readings was o5 mm Hg, the average of the two readings was recorded. If the difference was 45 mm Hg, additional measurements were performed to obtain stable readings, and the average of two stable readings was recorded.
Renal function
Estimated glomerular filtration rate (eGFR) was calculated using the following equation:
eGFR (ml min À1 1.73 m À2 ) ¼ 194 Â creatinine( À1.094) Â age( À0.287) ( Â 0.739 if female). 18 
Ultrasonographic determination
A trained technician examined the echocardiograms and carotid ultrasonograms (Power Vision 6000; Toshiba, Tokyo, Japan) and used the mean of three examinations as a representative measurement. Plaque score and the mean IMT of the carotid artery were determined by carotid ultrasonography as previously reported; 19 to obtain the plaque score, protruding lesions with an IMT X1.1 mm were defined as atheromatous plaque. Plaque score was calculated by summing all the plaque thickness measurements in both carotid arteries (S1 to S4).
Target organ damage and associated clinical conditions
We evaluated target organ damage (TOD) and associated clinical conditions according to the 2007 guidelines for arterial hypertension management from the European Society of Hypertension and the European Society of Cardiology. 20 Cerebrovascular disease was assessed by brain MRI, CT and neurological findings. Coronary artery disease was assessed by ECG, echocardiogram and typical symptoms. Lacunar infarcts were evaluated by brain MRI. Patients with diabetes mellitus were diagnosed according to the following diagnosis criteria of the American Diabetes Association: fasting plasma glucose at or above 126 mg dl À1 , HbA1c X6.5%, a 2-h value in an oral glucose tolerance test at or above 200 mg dl À1 , a random plasma glucose concentration X200 mg dl À1 in the presence of symptoms, or if the patient was taking drugs for diabetes. Patients were diagnosed with hyperlipidemia under the following conditions: total cholesterol X220 mg dl À1 , low-density lipoprotein cholesterol X140 mg dl À1 , triglycerides X150 mg dl À1 , or if the patient was taking drugs for hyperlipidemia.
PWV measurement
We assessed cfPWV as a representative PWV to evaluate arterial stiffness. For the PWV measurements, participants visited the hospital in the morning and were instructed not to take any antihypertensive drugs, nitrate or aspirin for 8 h preceding their visit. Measurements were performed in a controlled environment at 22 ± 2 1C with each patient in the supine position after 30 min of rest: a model FCP-4731 pulsimeter (Fukuda Denshi, Tokyo, Japan) that allowed on-line pulse wave recording and automatic calculation was used in accordance with a previously reported method. 21 Three measurements were taken at intervals of 2 min and averaged. The intra-observer coefficient of variation was 2.8 ± 1.2%, which was calculated using three measurements each from seven healthy men.
Statistical analysis
Data were analyzed using JMP ver. 9.0.1 (SAS, Cary, NC, USA) and are presented as the mean ± s.e.m. An event-free curve was estimated using the Kaplan-Meier method. The Wilcoxon test was used to compare differences in event-free rates between groups of subjects with different IMT and plaque scores. A Cox proportional hazards model was used to detect the relative risks of IMT and plaque score on the prognoses. Analysis of variance and Student's t-test were used to test for significant differences among groups of patients with different mean IMT or plaque scores. A P-value o0.05 was considered significant.
RESULTS
During a mean follow-up period of 6.4±0.2 years, 37 individuals had a stroke, 24 individuals developed CVD and 37 individuals died. Table 1 shows the baseline clinical characteristics of the patients. First, we divided our subjects into three groups according to the level of the mean IMT (IMTX1.0, n ¼ 85; 1.04IMTX0.7, n ¼ 168; IMTo0.7, n ¼ 103) and compared the characteristics among these three groups. Subjects with a higher mean IMT showed significantly a higher maleto-female ratio, age, prevalence of diabetes mellitus, plaque score, smoking index, and pulse pressure, and they showed a significantly lower eGFR and high-density lipoprotein cholesterol level (Table 1) . We also divided the subjects into three groups according to the plaque score (plaque score ¼ 0, n ¼ 171; 0oplaque scoreo5, n ¼ 116; plaque scoreX5, n ¼ 69) and compared the characteristics among these three groups. Subjects with a higher plaque score showed a significantly higher age, IMT, ratio of current smoking, smoking index, systolic blood pressure, pulse pressure and uric acid, and they showed a significantly lower eGFR (Table 1) .
Next, to investigate the relationship of the mean IMT and plaque score with TOD, we divided our subjects into three groups according to the level of TOD and compared the mean IMT and plaque score among these three groups. Subjects with associated clinical conditions (0.916 ± 0.020) showed a significantly higher IMT than subjects with TOD (0.860 ± 0.012; P ¼ 0.0058) and subjects without TOD (0.683±0.009; Po0.0001). Subjects with TOD also showed a significantly higher IMT than subjects without TOD (Po0.0001). Similarly, the plaque scores of the subjects with associated clinical conditions (5.787±0.688) were significantly higher than those of either the subjects with TOD (2.728 ± 0.290; P ¼ 0.0002) or the subjects without TOD (0.568 ± 0.132; Po0.0001). Subjects with TOD also showed significantly higher plaque scores than subjects without TOD (Po0.0001) (Figure 1a) .
To assess the relationship of the IMT and plaque score with cardiac atherosclerotic change and microvascular atherosclerotic change, we compared the IMT and plaque score of subjects with and without left ventricular hypertrophy and subjects with and without proteinuria. Subjects with left ventricular hypertrophy showed a significantly higher IMT (0.873±0.021 vs. 0.819±0.011; P ¼ 0.0119) and higher plaque scores (4.334 ± 0.680 vs. 2.613 ± 0.248; P ¼ 0.0305) than subjects without left ventricular hypertrophy. Subjects with proteinuria also showed a significantly higher IMT (0.872±0.023 vs. 0.823 ± 0.010; P ¼ 0.0305) and higher plaque scores (4.276 ± 0.729 vs. 2.774 ± 0.264; P ¼ 0.0279) than subjects without proteinuria (Figure 1b) . We also investigated the relationship of the IMT and plaque score with arterial stiffness evaluated by PWV, and we showed that both the IMT (R 2 ¼ 0.1032, Po0.0001) and plaque score (R 2 ¼ 0.2012, Po0.0001) were significantly correlated with PWV ( Figure 2 ). In addition, both the IMT (R 2 ¼ 0.1612, Po0.0001) and plaque score (R 2 ¼ 0.0612, Po0.0001) were significantly correlated with age ( Figure 2) .
Kaplan-Meier analysis revealed that subjects with a higher mean IMT and plaque score showed a higher frequency of stroke (P ¼ 0.0398 and P ¼ 0.0005, respectively). The rates of coronary heart disease did not significantly differ between subjects with a higher IMT and those with a lower IMT (P ¼ 0.6696) or between subjects in different plaque score groups (P ¼ 0.6449). Subjects with a higher mean IMT and plaque score showed higher mortality rates (P ¼ 0.0299 and P ¼ 0.0005, respectively) ( Figure 3a) . Notably, subjects with a mean IMT of X0.7 showed a significantly higher frequency of stroke than subjects with a mean IMTo0.7, although subjects with a mean IMT value of X1.0 did not show a different frequency of stroke from subjects with a mean IMTo1.0 (Figure 3b) . Subjects who experienced a stroke showed a significantly higher age, plaque score, mean IMT, systolic blood pressure (SBP) and diastolic blood pressure, and showed a significantly lower eGFR than subjects who did not experience a stroke (Table 2) . Subjects who died in the follow-up period showed a significantly higher male-to-female ratio, age, plaque score, mean IMT, smoking index and pulse pressure, and they showed a significantly lower BMI and eGFR than subjects who did not die in the follow-up period (Table 2) .
Finally, we examined whether the IMT and plaque score could predict the onset of stroke or mortality and whether this prediction was independent of other traditional risk factors (age, sex, diabetes mellitus and dyslipidemia) and systolic blood pressure. The Cox proportional hazards model with the end point of stroke indicated that plaque score was significantly and independently predictive of stroke. In contrast, the Cox proportional hazards model with the end point of death indicated that the IMT and plaque score showed only nonsignificant trends of higher risk of mortality after adjustment for traditional risk factors and SBP (Table 3) . Additionally, to compare the predictive ability of the IMT or plaque score with that of PWV, which is well known to be correlated with the onset of cardiovascular events, we classified our subjects into three groups according to their tertile of cfPWV. The Cox proportional hazards model with the end point of stroke showed that after adjustment for traditional risk factors and SBP, the relative risk among the first tertile of cfPWV Carotid plaque score and stroke in hypertension T Kawai et al compared with the third tertile of cfPWV was 3.24 (P ¼ 0.0238), and the relative risk among the second tertile of cfPWV compared with the third tertile of cfPWV was 1.81 (P ¼ 0.2722). Similarly, the Cox proportional hazards model with the end point of death showed that after adjustment for traditional risk factors and SBP, the relative risk among the first tertile of cfPWV compared with the third tertile of cfPWV was 15.18 (P ¼ 0.0001), and the relative risk among the second tertile of cfPWV compared with the third tertile of cfPWV was 5.33 (P ¼ 0.0569).
DISCUSSION
The mean IMT and plaque score have both been widely used as surrogate markers for systemic atherosclerotic change. In this study, we showed that both markers were strongly correlated with each other (as previously reported) and were significantly positively correlated with age, smoking index, pulse pressure, TOD, left ventricular mass index and proteinuria and that they were negatively correlated with eGFR. We also showed that the subjects who experienced a stroke or who died in the follow-up period had a higher plaque score and mean IMT. We also revealed differences between the IMT and plaque scores concerning the correlations with systemic atherosclerotic change and prognosis. IMT and plaque score are well known to reflect macrovascular atherosclerosis, 9 and PWV is well known to reflect arterial stiffness. 7 Although these parameters are widely used as surrogate markers for CVDs, there have been no studies, to our knowledge, that compare the predictive ability for cardiovascular events among IMT, plaque score and PWV. We compared the predictive ability of IMT or plaque Carotid plaque score and stroke in hypertension T Kawai et al score with that of PWV for the onset of stroke and total mortality in the present cohort. We showed that the relative risk of stroke that was predicted by plaque score was equivalent to that predicted by PWV, which was previously reported to be an independent predictor of all CVD including stroke. 17 This result indicated that plaque score could predict the onset of stroke as well as PWV, although PWV could predict death more accurately than plaque score or IMT. As many study subjects were already receiving medical treatment for hypertension, we could not show significant correlations of SBP and diastolic blood pressure with other parameters; however, pulse pressure was significantly correlated with the mean IMT and plaque score. Pulse pressure reportedly rises as the aorta stiffens with aging or atherosclerotic disease progression. 22, 23 Increased pulse pressure is also reportedly associated with CVD. [24] [25] [26] Our results revealed that both the plaque score and the mean IMT were significantly correlated with the PWV; additionally, the coefficient of determination between the PWV and the plaque score was larger than that between the PWV and the mean IMT (0.2021 vs. 0.1032). As PWV represents arterial stiffness, 27 our result suggests that plaque score reflects increased arterial stiffness more strongly than mean IMT.
It is controversial as to which index, the mean IMT or the plaque score, predicts stroke more accurately. Previous analyses of subjects with various conditions have shown plaque score 28 and IMT 29 to be more significantly correlated with abnormal cerebral findings evaluated by brain MRI. Lee et al. 30 reported that both the IMT and the plaque score were associated with acute ischemic stroke in patients with type 2 diabetes. In the present study, both the mean IMT and the plaque score were significantly correlated with the onset of stroke. We also showed that the plaque score, but not the mean IMT, was significantly correlated with the onset of stroke even after adjustment for other traditional risk factors, indicating that the plaque score could be a more effective marker than the mean IMT for predicting stroke in patients with essential hypertension. Stroke is influenced by the duration and severity of pressure overload caused by longitudinal increase in blood pressure, 31 which are factors that are also predicted by PWV. 27 Hence, the stronger correlation between plaque score and PWV might explain why plaque score more accurately predicted stroke onset.
Notably, subjects with a mean IMT of X0.7 showed significantly higher frequency of stroke than subjects with a mean IMT of o0.7; however, subjects with a mean IMT of X1.0 did not show a difference in their frequency of stroke compared with subjects with a mean IMT of o1.0. IMT reflects adaptive arterial wall changes in response to shear stress. Previous studies indicated that the IMT is mainly correlated with hypertension, 32 thus the mean IMT in hypertensive patients is thought to be influenced by routine high blood pressure. Therefore, unlike in cases of other subjects with high cardiovascular risk (for example, those with diabetes and hypercholesterolemia), marginal thickening of the mean IMT could predict CVD in hypertensive patients. However, because only 24 of our subjects developed coronary heart disease, we did not show a significant correlation between coronary heart disease and either the mean IMT or the plaque score, although such correlations were reported in previous studies. 11, 33 This study has several limitations. First, this cohort study was hospital-based and included a relatively small number of patients. In addition, because the present study was conducted at a university medical hospital that specializes in hypertensive treatment and serves many high-risk patients who are referred to the hospital from general physicians, our study cohort consisted of high-risk patients. We think this is the reason why the event rate in this study was high (B4% per year) compared with other cohort studies such as the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial 34 or a There were no significant differences in the incidence of coronary heart disease among subjects in different mean IMT groups (c) or in different plaque score groups (d). Subjects with a higher mean IMT (e) or a higher plaque score (f) showed significantly higher mortality rates. (B) Kaplan-Meier analysis for stroke. (a) Subjects with a higher IMT (IMTX0.7) showed a significantly higher incidence of stroke. (b) There were no significant differences in the incidence of coronary heart disease between subjects with a higher IMT and those with a lower mean IMT.
Japanese trial on the prognostic implication of PWV (J-TOPP). 35 Therefore, multi-center trials with a larger cohort are needed to confirm the results of our study. Secondly, at enrollment, many subjects had already been treated with various medications, such as angiotensin receptor type II blockers, angiotensin-converting enzyme inhibitors, or statins, which might contribute to better outcomes.
In conclusion, we showed that both the mean IMT and the plaque score were significantly correlated with arterial stiffness and TOD. We also revealed new evidence that the plaque score could more accurately predict the onset of stroke in hypertensive patients, and we also showed that marginal increases in the mean IMT could be a predictor of stroke. 
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